These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19543877)

  • 1. [Neuro-enhancement from an addiction specialist's viewpoint].
    Soyka M
    Nervenarzt; 2009 Jul; 80(7):837-9. PubMed ID: 19543877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuro-enhancement. Brain doping].
    Förstl H
    Nervenarzt; 2009 Jul; 80(7):840-6. PubMed ID: 19565292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cognitive enhancement medication among northern Italian university students.
    Castaldi S; Gelatti U; Orizio G; Hartung U; Moreno-Londono AM; Nobile M; Schulz PJ
    J Addict Med; 2012 Jun; 6(2):112-7. PubMed ID: 22456492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Just treat, or enhance?
    Kennedy D
    Science; 2004 Apr; 304(5667):17. PubMed ID: 15060288
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions.
    Tomažič T; Čelofiga AK
    Philos Ethics Humanit Med; 2019 Apr; 14(1):7. PubMed ID: 31023334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American culture and neuro-cognitive enhancing drugs.
    Flaskerud JH
    Issues Ment Health Nurs; 2010 Jan; 31(1):62-3. PubMed ID: 19951164
    [No Abstract]   [Full Text] [Related]  

  • 8. Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults.
    Dubljević V
    Am J Bioeth; 2013; 13(7):23-33. PubMed ID: 23767434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards responsible use of cognitive-enhancing drugs by the healthy.
    Greely H; Sahakian B; Harris J; Kessler RC; Gazzaniga M; Campbell P; Farah MJ
    Nature; 2008 Dec; 456(7223):702-5. PubMed ID: 19060880
    [No Abstract]   [Full Text] [Related]  

  • 10. [Brain doping: self exploitation by pill].
    Klein F
    MMW Fortschr Med; 2011 Sep; 153(35):21. PubMed ID: 21919245
    [No Abstract]   [Full Text] [Related]  

  • 11. Part II. Cognitive domains for pharmacological intervention: implications for neuropsychiatric and neurological illnesses.
    Handb Exp Pharmacol; 2015; 228():157-9. PubMed ID: 26317140
    [No Abstract]   [Full Text] [Related]  

  • 12. From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate.
    Busardò FP; Kyriakou C; Cipolloni L; Zaami S; Frati P
    Curr Neuropharmacol; 2016; 14(1):17-27. PubMed ID: 26813119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological cognitive enhancement from a perspective of misuse and addiction].
    Franke AG; Soyka M
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):83-90. PubMed ID: 25723772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experts urge smart thinking on cognitive enhancers.
    Morris K
    Lancet Neurol; 2008 Jun; 7(6):476-7. PubMed ID: 18485312
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers.
    Dunbar G; Boeijinga PH; Demazières A; Cisterni C; Kuchibhatla R; Wesnes K; Luthringer R
    Psychopharmacology (Berl); 2007 May; 191(4):919-29. PubMed ID: 17225162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focusing the Neuroscience and Societal Implications of Cognitive Enhancers.
    Savulich G; Piercy T; Brühl AB; Fox C; Suckling J; Rowe JB; O'Brien JT; Sahakian BJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):170-172. PubMed ID: 27557349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Using ginseng root and other herbal adaptogens as nootropic drugs].
    Arushanian EB
    Eksp Klin Farmakol; 2008; 71(6):58-66. PubMed ID: 19140520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.
    Fond G; Micoulaud-Franchi JA; Brunel L; Macgregor A; Miot S; Lopez R; Richieri R; Abbar M; Lancon C; Repantis D
    Psychiatry Res; 2015 Sep; 229(1-2):12-20. PubMed ID: 26187342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive effects of creatine ethyl ester supplementation.
    Ling J; Kritikos M; Tiplady B
    Behav Pharmacol; 2009 Dec; 20(8):673-9. PubMed ID: 19773644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK
    Hum Psychopharmacol; 2012 Nov; 27(6):527-33. PubMed ID: 23001963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.